abstract |
The present invention relates to the progression of atherosclerosis-related disease in a patient by administering to the patient an amount of rifamycin effective to treat, prevent or reduce the progression of atherosclerosis-related disease in the patient. Characterized by a method of treating, preventing, or alleviating |